TABLE 1.
Group name | Group description | Number of animals |
|||
PCR | Neurological studies | Mortality and exclusion | Total | ||
Sham | Rats subjected to surgical procedure as MCAO rats, but no sutures were inserted. | 6♂ | – | – | 6♂ |
Untreated | Rats subjected to MCAO but received no treatment | 18♂ | – | 7♂ | 25♂ |
SVsh treated SVsh-IAR/ SVsh-SD |
Rats subjected to MCAO and received SVsh treatment immediately (within 30 min) after reperfusion. | – | 18♂ + 13♀ | 12♂ + 7♀ | 30♂ + 20♀ |
SVsh-RD | Rats subjected to MCAO and received SVsh treatment immediately (within 30 min) after reperfusion and on post-reperfusion days 7 and 14. | – | 8♂ | 4♂ | 12♂ |
M12sh treated M12sh-IAR/ M12sh-SD |
Rats subjected to MCAO and received M12sh treatment immediately (within 30 min) after reperfusion. | 18♂ | 18♂ + 12♀ | 15♂ + 5♀ | 51♂ + 17♀ |
M12sh-3hAR | Rats subjected to MCAO and received M12sh treatment 3h after reperfusion. | – | 12♂ | 5♂ | 17♂ |
M12sh-6hAR | Rats subjected to MCAO and received M12sh treatment 6h after reperfusion. | – | 12♂ | 6♂ | 18♂ |
M12sh-RD | Rats subjected to MCAO and received M12sh treatment immediately (within 30 min) after reperfusion and on post-reperfusion days 7 and 14. | – | 10♂ + 10♀ | 4♂ + 6♀ | 14♂ + 16♀ |
♂, Male; ♀, female; MCAO, middle cerebral artery occlusion; PCR, polymerase chain reaction; AR, after reperfusion; SD, single dose; RD, repeated dose.